Sai Parenteral's
SAIPARENT •NSE

Sai Parenteral's

₹483.00-4.30 (0.88%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
482.10
Today’s high
490.75
52 week low
400.00
52 week high
706.00
Open price
483.20
Previous close
487.30
Live volume
65,785
Lower circuit
386.40
Upper circuit
579.60

Fundamentals

Market Cap
₹2,134Cr
ROE
2.91%
P/E Ratio(TTM)
102.77
EPS(TTM)
4.70
P/B Ratio
4.35
Dividend Yield
0.00%
Industry P/E
36.35
Book Value
111.09
Debt to Equity
0.68
Face Value
5

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹182Cr
-9.16%
₹7.92Cr
-39.82%
-75075150225
Jun '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
3Y CAGR+59%
Profit growthValue
3Y CAGR+48%

About

Sai Parenterals is a diversified pharmaceutical formulations company. While it started as a specialist in "parenterals" (injectables), it has evolved into a multi-dosage platform. Its business is split into two main verticals:Branded Generic Formulations and CDMO (Contract Development and Manufacturing). The company covers high-growth therapeutic areas such as cardiovascular, anti-diabetic, neuropsychiatry, and oncology. It operates five manufacturing facilities—four in Hyderabad (Telangana) and one in Ongole (Andhra Pradesh).;
CEO/MD
Anil Kumar Karusala
Founded in
2001
NSE symbol
SAIPARENT

Shareholding pattern

Sep '25
Mar '26
Apr '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹3,808.70
-5.30 (0.14%)
L
    H
    17,417.0823.694.14
    ₹2,258.80
    -42.50 (1.85%)
    L
      H
      17,194.2325.365.1
      Natco PharmaNATCOPHARM
      ₹800.85
      +15.80 (2.01%)
      L
        H
        15,708.1513.721.5
        ₹6,039.50
        +69.00 (1.16%)
        L
          H
          15,108.2589.0717.31
          Livesquawk •
          SAI Parenterals' Q1 EBITDA surged to ₹235M from ₹47M YoY. Q1 EBITDA margin declined to 13.2% from 14.2% YoY.
          2026
          11
          Aug
          Quarterly Result
          Release date
          23
          May
          Quarterly & Annual Result
          Release date
          Events calendar
          View upcoming events in other stocks